Financials

  • Market Capitalization 5.61 M
  • Employee 6
  • Founded 2009
  • CEO N/A
  • Website www.kalarx.com
  • Headquarter Delaware, United States
  • FIGI BBG001J2MVT8
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.17
Relación precio/flujo de caja
—

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4809
CDIO
Cardio Diagnostics Holdings Inc. - Common stock
1.91 USD+2.69%-3.54%-5.91%-27.24%5.65 M USD
4811
BGMS
Bio Green Med Solution, Inc. - Common Stock
0.85 USD+3.66%-5.56%0.00%-81.99%5.63 M USD
4816
CELZ
Creative Medical Technology Holdings, Inc. - Common Stock
0.84 USD-2.33%-11.58%-11.58%-75.29%5.54 M USD
4817
LEXX
Lexaria Bioscience Corp. - Common Stock
3.32 USD-1.19%+14.48%-16.58%+300.00%5.49 M USD

Noticias